<qa>  What is the main motivation of the trial drug?Intraoperative intravitreal 5-fluorouracil 5-FU and low molecular weight heparin LMWH is used as a prophylactic therapy in high-risk patients with primary rhegmatogenous retinal detachment RRD. Our major motivation is to reduce the incidence of PVR in the group that receives the trial drug. 